Unichem Laboratories Ltd
NSE: UNICHEMLAB BSE: 506690
₹346.20
(-1.18%)
Mon, 09 Mar 2026, 08:21 pm
Market Cap24.44B
PE Ratio8.28
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KUnichem Laboratories Financials
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.47B | 6.22B | 6.66B | 7.30B | 7.44B | 8.20B | 8.66B | 10.72B | 11.18B | 11.88B | 13.18B | 6.79B | 7.82B | 11.39B | 10.67B | 12.05B | 12.56B | 13.25B | 17.47B | 20.81B |
| Gross profit | 793.89M | 2.27B | 2.46B | 3.06B | 3.25B | 3.42B | 3.29B | 4.12B | 4.31B | 4.07B | 4.92B | 1.94B | 813.38M | 2.56B | 1.69B | 3.01B | 2.73B | 1.39B | 3.15B | 5.10B |
| Operating expenses (excl. COGS) | — | -1.52B | -1.78B | -1.93B | -1.75B | -2.24B | -2.50B | -2.84B | -3.14B | -3.61B | -3.64B | -2.96B | -2.91B | -4.31B | -3.35B | -3.21B | -2.98B | -3.12B | -5.15B | -4.00B |
| Selling/general/admin expenses, total | — | -1.47B | -1.70B | -1.86B | -1.70B | -2.19B | -2.41B | -2.74B | -3.03B | -3.48B | -3.63B | -2.90B | -2.87B | -4.28B | -3.30B | -3.17B | -2.94B | -3.05B | -3.85B | -3.96B |
| Research & development | -100.63M | -196.68M | -321.50M | -272.13M | -291.18M | -383.51M | -392.74M | -364.93M | -521.51M | -464.21M | -438.68M | -616.94M | -849.69M | -1.16B | -1.56B | -1.30B | -1.13B | -1.09B | -1.05B | -900.00M |
| Selling/general/admin expenses, other | — | -1.27B | -1.38B | -1.59B | -1.41B | -1.80B | -2.01B | -2.38B | -2.50B | -3.01B | -3.19B | -2.28B | -2.02B | -3.12B | -1.74B | -1.87B | -1.81B | -1.96B | -2.80B | -3.06B |
| Other operating expenses, total | — | -52.68M | -83.50M | -69.40M | -49.34M | -58.36M | -94.45M | -104.15M | -118.60M | -126.29M | -8.40M | -58.03M | -46.01M | -28.58M | -47.71M | -42.30M | -36.04M | -65.30M | -1.30B | -38.70M |
| Operating income | 746.23M | 747.16M | 677.89M | 1.13B | 1.50B | 1.18B | 786.34M | 1.28B | 1.17B | 461.23M | 1.28B | -1.02B | -2.10B | -1.75B | -1.66B | -197.09M | -243.56M | -1.73B | -2.00B | 1.10B |
| Non-operating income, total | 152.80M | 100.18M | -22.06M | 116.64M | 31.08M | 91.50M | 153.96M | 184.05M | 542.50M | 312.90M | 101.06M | 190.12M | 803.09M | 1.15B | 1.17B | 715.31M | 473.86M | -34.87M | 1.15B | 446.90M |
| Interest expense, net of interest capitalized | -38.24M | -24.87M | -21.95M | -25.55M | -23.83M | -23.92M | -40.78M | -32.90M | -31.90M | -30.42M | -28.96M | -33.59M | -80.08M | -75.22M | -78.47M | -50.50M | -61.05M | -173.12M | -226.60M | -210.30M |
| Interest capitalized | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29.49M | 11.25M | 0 | 8.90M |
| Non-operating income, excl. interest expenses | 57.17M | 149.68M | 53.36M | 142.19M | 54.91M | 115.42M | 194.74M | 216.95M | 574.40M | 343.32M | 155.45M | 210.37M | 752.30M | 1.01B | 970.69M | 649.39M | 534.96M | 417.37M | 1.31B | 564.60M |
| Non-operating interest income | 21.91M | 12.64M | 7.61M | 6.58M | 13.42M | 14.57M | 16.11M | 4.03M | 57.29M | 93.50M | 51.28M | 25.14M | 135.23M | 449.79M | 386.92M | 229.40M | 64.78M | 5.16M | 6.70M | 28.50M |
| Miscellaneous non-operating expense | 35.26M | 137.04M | 45.75M | 135.61M | 41.50M | 100.84M | 178.63M | 212.92M | 517.11M | 249.82M | 104.17M | 185.22M | 617.08M | 563.93M | 583.77M | 419.99M | 470.18M | 412.21M | 1.30B | 536.10M |
| Unusual income/expense | 133.87M | -24.63M | -53.47M | — | — | — | — | — | — | — | -25.43M | 13.34M | 130.86M | 215.05M | 273.53M | 116.42M | -43.00K | -279.12M | 64.70M | 92.60M |
| Pretax income | 899.03M | 847.34M | 655.83M | 1.24B | 1.53B | 1.27B | 940.30M | 1.46B | 1.71B | 774.13M | 1.38B | -827.64M | -1.30B | -599.71M | -490.23M | 518.22M | 230.30M | -1.76B | -849.60M | 1.55B |
| Taxes | -111.38M | -145.67M | -141.96M | -163.38M | -301.04M | -317.92M | -227.72M | -328.47M | -430.04M | -21.32M | -292.99M | 118.53M | -33.42M | 343.48M | -119.72M | -171.55M | 110.93M | -258.65M | -88.00M | -170.70M |
| Non-controlling/minority interest | -2.88M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 784.77M | 701.67M | 513.87M | 1.08B | 1.23B | 949.94M | 712.58M | 1.13B | 1.28B | 753.90M | 1.08B | -707.23M | -1.33B | -255.58M | -601.83M | 343.25M | 330.62M | -2.02B | -937.60M | 1.38B |
| Net income | 784.77M | 701.67M | 513.87M | 1.08B | 1.23B | 949.94M | 712.58M | 1.13B | 1.28B | 753.90M | 1.08B | 1.09B | -6.72B | -238.00M | -601.83M | 343.25M | 330.62M | -2.02B | -937.60M | 1.38B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 784.77M | 701.67M | 513.87M | 1.08B | 1.23B | 949.94M | 712.58M | 1.13B | 1.28B | 753.90M | 1.08B | 1.09B | -6.72B | -238.00M | -601.83M | 343.25M | 330.62M | -2.02B | -937.60M | 1.38B |
| Basic earnings per share (Basic EPS) | 9.14 | 7.8 | 5.7 | 11.99 | 13.66 | 10.53 | 7.89 | 12.52 | 14.15 | 8.31 | 11.9 | 11.96 | -74.14 | -3.38 | -8.55 | 4.88 | 4.7 | -28.72 | -13.32 | 19.53 |
| Diluted earnings per share (Diluted EPS) | 9.12 | 7.79 | 5.7 | 11.98 | 13.58 | 10.47 | 7.86 | 12.48 | 14.1 | 8.29 | 11.88 | 11.94 | -74.14 | -3.38 | -8.55 | 4.88 | 4.68 | -28.72 | -13.32 | 19.47 |
| EBITDA | 872.73M | 887.14M | 859.31M | 1.35B | 1.73B | 1.47B | 1.09B | 1.66B | 1.63B | 873.96M | 1.66B | -582.60M | -1.59B | -1.08B | -839.28M | 646.48M | 668.10M | -594.32M | -765.10M | 2.34B |
| EBIT | 746.23M | 747.16M | 677.89M | 1.13B | 1.50B | 1.18B | 786.34M | 1.28B | 1.17B | 461.23M | 1.28B | -1.02B | -2.10B | -1.75B | -1.66B | -197.09M | -243.56M | -1.73B | -2.00B | 1.10B |
| Total operating expenses | -4.73B | -5.48B | -5.98B | -6.17B | -5.94B | -7.02B | -7.88B | -9.45B | -10.01B | -11.42B | -11.91B | -7.81B | -9.92B | -13.15B | -12.33B | -12.25B | -12.80B | -14.98B | -19.47B | -19.71B |
| Prepaid expenses | — | 8.32M | 5.94M | 12.97M | 15.26M | 26.42M | 54.52M | 83.55M | 55.39M | 104.20M | 143.31M | 264.66M | 273.30M | 395.54M | 407.91M | 354.80M | 210.48M | 234.31M | 211.30M | 221.20M |
| Deferred income, current | — | — | — | — | — | — | — | — | — | — | — | — | 46.16M | 15.58M | 100.89M | 282.88M | 269.49M | 245.27M | 76.90M | 9.70M |
| Capital and operating lease obligations | 0 | 0 | 0 | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 143.10M | 143.10M | 145.71M | 114.93M | 251.90M | 251.90M |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | — | 297.27M | 353.69M | 354.68M | 390.92M | 434.25M | 458.46M | 459.79M | 527.56M | 522.89M | 544.41M | 596.46M | 616.60M | 829.48M | 902.55M | 137.02M | 889.86M | 714.49M | 883.00M | 823.40M |
| Deferred income, non-current | — | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 46.92M | 46.92M | 46.92M | 46.92M | 46.92M | 10.95M | 8.70M | 6.40M |
| Minority interest | 213.76M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | 0 | 0 | 0 | — | — | — | — | — | — | — |
| Common dividends paid | -118.05M | -350.03M | -8.02M | -286.13M | -285.52M | -356.72M | -250.55M | -272.17M | -764.65M | -420.25M | -433.33M | -6.96M | -329.66M | -423.46M | -340.34M | -286.58M | -283.62M | -282.55M | -2.10M | -3.40M |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800